AKT1 and infection: Moving nucleocapsids were represented as continuous “tracks.” When N compartments were pretreated with LY294002, Akt inhibitor VIII, rapamycin, or cycloheximide, the number of moving nucleocapsids was reduced by ∼75.8% ± 24.4%, ∼76.3% ± 24.4%, ∼79% ± 22.8%, or ∼75.8% ± 40.8%, respectively, compared to PRV 180 infection alone (Fig. 3C).